Related Experiment Video
Updated: May 24, 2026

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
Published on: May 4, 2016
Melatonin-induced autophagy protects against human prion protein-mediated neurotoxicity
Jae-Kyo Jeong1, Myung-Hee Moon, You-Jin Lee
1Korea Zoonoses Research Institute, Bio-Safety Research Institute, Center for Healthcare Technology Development, College of Veterinary Medicine, Chonbuk National University, Jeonju, Korea.
Abstract:
Melatonin has neuroprotective effects in the models of neurodegenerative disease including Alzheimer's and Parkinson's disease. Several studies have shown that melatonin prevents neurodegeneration by regulation of mitochondrial function. However, the protective action of melatonin has not been reported in prion disease. We investigated the influence of melatonin on prion-mediated neurotoxicity. Melatonin rescued neuronal cells from PrP(106-126)-induced neurotoxicity by prevention of mitochondrial dysfunction. Moreover, the protective effect of melatonin against mitochondrial dysfunction was related with autophagy activation. Melatonin-treated cells were dose-dependently increased in LC3-II, an autophagy marker. Melatonin-induced autophagy prevented a PrP(106-126)-induced reduction in mitochondrial potential and translocation of Bax to the mitochondria and cytochrome c release. On the other hand, downregulation of autophagy protein 5 with Atg5 siRNA or the autophagy blocker 3-methyladenine prevented the melatonin-mediated neuroprotective effects. This is the first report demonstrating that treatment with melatonin appears to protect against prion-mediated neurotoxicity and that the neuroprotection is induced by melatonin-mediated autophagy signals. The results of this study suggest that regulation of melatonin is a therapeutic strategy for prion peptide-induced apoptosis.
Insights
Melatonin protects against prion peptide neurotoxicity by activating autophagy, which preserves mitochondrial function. This study reveals melatonin
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Melatonin exhibits neuroprotective properties in Alzheimer's and Parkinson's disease models.
- Its protective mechanisms often involve regulating mitochondrial function.
- The role of melatonin in prion diseases remains unexplored.
Purpose of the Study:
- To investigate the neuroprotective effects of melatonin against prion peptide-induced neurotoxicity.
- To elucidate the underlying mechanisms, particularly the involvement of mitochondrial function and autophagy.
Main Methods:
- Neuronal cells were exposed to prion peptide PrP(106-126) with or without melatonin treatment.
- Mitochondrial function was assessed by measuring mitochondrial potential, Bax translocation, and cytochrome c release.
- Autophagy activation was evaluated by monitoring LC3-II levels and by using siRNA to downregulate autophagy protein 5 (Atg5) or employing an autophagy inhibitor (3-methyladenine).
Main Results:
- Melatonin treatment rescued neuronal cells from PrP(106-126)-induced neurotoxicity.
- Melatonin prevented mitochondrial dysfunction, including loss of mitochondrial potential and altered Bax/cytochrome c.
- Melatonin dose-dependently increased LC3-II, indicating autophagy activation.
- Inhibition of autophagy abolished the neuroprotective effects of melatonin.
Conclusions:
- Melatonin demonstrates neuroprotective effects against prion peptide-mediated neurotoxicity.
- Melatonin-induced autophagy plays a crucial role in this neuroprotection by maintaining mitochondrial integrity.
- Targeting melatonin pathways represents a potential therapeutic strategy for prion peptide-induced apoptosis.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
